The Eurasian Economic Union’s common market for medical technology products retains a headline target of starting to take device submissions before the end of the year. To many, including Alexey Stepanov, regulatory manager for Russia and the CIS with Abbott Molecular Inc., this is an unlikely eventuality.
Addressing the "emerging markets regulatory affairs" stream of Informa Life Sciences Medtech Summit 2016 in Brussels (June 13-16), Stepanov provided a brief journey-so-far for the three already-integrated members of the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?